The Influence of CYP2C19 Genetic Polymorphism on the Pharmacokinetics/- Pharmacodynamics of Proton Pump Inhibitor-Containing Helicobacter pylori Treatments

By  

Current Drug Metabolism, Vol. 13, Iss. 9, 2012-11 ,pp. : 1303-1312

Bentham Science Publishers

Access to resources Recommend Favorite

Relationship between the Acid-inhibitory Effects of Two Proton Pump Inhibitors and CYP2C19 Genotype in Japanese Subjects: a Randomized Two-way Crossover Study

By Furuta K   Adachi K   Ohara S   Morita T   Tanimura T   Koshino K   Kinoshita Y  

The Journal of International Medical Research, Vol. 38, Iss. 4, 2010-07 ,pp. : 1473-1483

Field House Publishing

Access to resources Recommend Favorite

Effects of Eradication Therapy on Gastric Emptying in Patients with Helicobacter pylori-positive Duodenal Ulcers

By Onuk MD   Uslu H   Varoğlu E  

The Journal of International Medical Research, Vol. 29, Iss. 3, 2001-05 ,pp. : 178-180

Field House Publishing

Access to resources Recommend Favorite

CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor

By Furuta Takahisa   Sugimoto Mitsushige   Shirai Naohito   Ishizaki Takashi  

Pharmacogenomics, Vol. 8, Iss. 9, 2007-09 ,pp. : 1199-1210

Future Medicine

Access to resources Recommend Favorite

Interaction Between Clopidogrel and Proton Pump Inhibitors: Hypothesis to Explain Multifactorial CYP2C19 Inhibition

By  

Drug Metabolism Letters, Vol. 3, Iss. 4, 2009-12 ,pp. : 287-289

Bentham Science Publishers

Access to resources Recommend Favorite